I am/have/had
I am looking for
Advanced Filters
Found 751 clinical trials
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
The purpose of this study is to test whether two investigational drugs called CAD106 and CNP520, administered separately, can slow down the onset and progression of clinical symptoms associated with Alzheimer's disease (AD) in participants at the risk to develop clinical symptoms based on their age and genotype.
Accepts healthy volunteers
mini-mental state examination
mental state examination
apolipoprotein e4
alzheimer's disease
- 32 views
- 20 Sep, 2024
- 127 locations
